Study of Sargramostim in Moderately to Severely Active Crohn's Disease
Clinical trial NCT00329537 · TERMINATED
Trial details
- NCT number
- NCT00329537
- Sponsor
- Genzyme, a Sanofi Company
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-06-01
- Primary completion
- 2007-05-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.